Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Profit After Tax: 2019-2025

Historic Profit After Tax for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $17.6 million.

  • Burning Rock Biotech's Profit After Tax fell 90.83% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.9 million, marking a year-over-year decrease of 107.45%. This contributed to the annual value of -$47.5 million for FY2024, which is 48.42% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Profit After Tax of $17.6 million as of Q3 2025, which was up 182.41% from -$21.3 million recorded in Q2 2025.
  • Burning Rock Biotech's Profit After Tax's 5-year high stood at $614.2 million during Q4 2022, with a 5-year trough of -$231.5 million in Q3 2022.
  • In the last 3 years, Burning Rock Biotech's Profit After Tax had a median value of -$21.3 million in 2025 and averaged $133,364.
  • Within the past 5 years, the most significant YoY rise in Burning Rock Biotech's Profit After Tax was 1,622.01% (2022), while the steepest drop was 771.09% (2022).
  • Over the past 5 years, Burning Rock Biotech's Profit After Tax (Quarterly) stood at -$40.4 million in 2021, then spiked by 1,622.01% to $614.2 million in 2022, then crashed by 34.97% to $399.4 million in 2023, then slumped by 102.42% to -$9.7 million in 2024, then plummeted by 90.83% to $17.6 million in 2025.
  • Its Profit After Tax was $17.6 million in Q3 2025, compared to -$21.3 million in Q2 2025 and -$13.5 million in Q1 2025.